P2X7 receptor is critical in α-synuclein–mediated microglial NADPH oxidase activation..
Neurobiol. Aging; doi: 10.1016/j.neurobiolaging.2015.03.015.
Stabilization of Alpha-Synuclein Oligomers In Vitro by the Neurotransmitters, Dopamine and Norepinephrine: The Effect of Oxidized Catecholamines.
Springer Link; DOI: 10.1007/s11064-015-1597-y.
Alpha Synuclein Shows High-Affinity Interaction with Voltage-Dependent Anion Channel Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease.
JBC Papers in Press; doi:10.1074/jbc.M115.641746.
Generation of human pluripotent stem cell reporter lines for the isolation of and reporting on astrocytes generated from ventral midbrain and ventral spinal cord neural progenitors.
ScienceDirect; doi:10.1016/j.scr.2015.05.014.
Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.
JNC Journal of Neurochemistry; DOI: 10.1111/jnc.13180.
α-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease.
The Journal of Biological Chemistry; doi: 10.1074/jbc.M115.641746.
Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1..
Acta Neuropathol Commun.; doi: 10.1186/s40478-014-0164-0..
Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays..
PLoS One; https://doi.org/10.1371/journal.pone.0114566.
Increased plasma oligomeric alpha-synuclein in patients with lysosomal storage diseases.
Science Direct; doi:10.1016/j.neulet.2014.09.041.
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease..
Acta Neurolpathol.; doi: 10.1007/s00401-014-1314-y.